Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 351

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 351
---
00 |     |           | 4.94 |

____________ (1)Assumes redemptions of 52,159 public shares of NorthView Common Stock in connection with the Business Combination, at approximately $12.21 per share based on the trust account balance as of March 21, 2025 subsequent to the March 21, 2025 redemptions. (2)Includes assumptions, presented under the two redemption scenarios, for New Profusa Common Stock issued and outstanding immediately after the Business Combination. (3)Excludes 4,033,530 founder shares of New Profusa Common Stock held by Sponsor and its affiliates and 450,000shares held by NorthView’s Representatives, but includes the 710,220shares that were utilized as inducement shares for the senior secured convertible note. (4)Assumes that 3,875,000 Earnout Shares are issued at the time of Closing, with no change to the implied equity value of New Profusa at the time of Closing. (5)Assumes that 9,487,500shares of New Profusa Common Stock are issued upon exercise of the NorthView Public Warrants, in exchange for $109.1 million in proceeds. (6)Assumes that 7,916,750shares of New Profusa Common Stock are issued upon exercise of the NorthView Private Placement Warrants (including 569,250 Representative Warrants), in exchange for $91.0 million in proceeds. (7)Assumes that 7,916,750shares of New Profusa Common Stock are issued upon exercise of the NorthView Private Placement Warrants (including 569,250 Representative Warrants), in exchange for $91.0 million in proceeds and 9,487,500shares of New Profusa Common Stock are issued upon exercise of the NorthView Public Warrants, in exchange for $109.1 million in proceeds. (8)Excludes 5,193,750shares of New Profusa Common Stock held by Sponsor and its affiliates, and assumes that 17,404,250shares of New Profusa Common Stock are issued upon exercise of the NorthView Public Warrants, in exchange for $200.1 million in proceeds. (9)Assumes that 2,444,444shares of New Profusa Common Stock (in addition to the 1,000,000shares included in the base scenario) are issued at a $5.00 conversion price. A sensitivity analysis with various conversion price assumptions is presented below.